Denosumab-Induced Osteonecrosis of the Jaw with FDG PET/CT imaging features.

Denosumab-Induced Osteonecrosis of the Jaw with FDG PET/CT imaging features.

Denosumab is a monoclonal antibody that inhibits receptor activator of nuclear factor-kappa B ligand (RANKL), which plays a crucial role in osteoclast formation, function, and survival. By blocking RANKL, denosumab helps prevent bone resorption, making it an effective therapeutic option for managin...

Full description

Bibliographic Details
Main Authors: SALONI RAJKOTIA, RITESH SUTHAR, ABHISHEK PALSAPURE
Format: Article
Language:English
Published: SJORANM GmbH (Ltd.) 2024-11-01
Series:Swiss Journal of Radiology and Nuclear Medicine
Subjects:
MANDIBLE
DENOSUMAB
OSTEONECROSIS
FDG PET/CT
Online Access:https://sjoranm.com/sjoranm/article/view/47

Similar Items

Similar Items